Notably, MDA-MB-231 and MDA-MB-468 cells exhibited the lowest expression levels of GPRC5A, while T47D and MCF7 cells exhibited the highest mRNA expression levels of GPRC5A among the breast cancer cell lines investigated. This evidence concerns the gene GPRC5A and breast carcinoma.